These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19413301)

  • 1. Light-activated Cre recombinase as a tool for the spatial and temporal control of gene function in mammalian cells.
    Edwards WF; Young DD; Deiters A
    ACS Chem Biol; 2009 Jun; 4(6):441-5. PubMed ID: 19413301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in the study of the structure and function of Cre recombinase].
    Wang LX; Wang Y; Hu YL; Gao Y; Lin ZP
    Sheng Wu Gong Cheng Xue Bao; 2002 Sep; 18(5):531-5. PubMed ID: 12561193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quasi-equivalence in site-specific recombinase structure and function: crystal structure and activity of trimeric Cre recombinase bound to a three-way Lox DNA junction.
    Woods KC; Martin SS; Chu VC; Baldwin EP
    J Mol Biol; 2001 Oct; 313(1):49-69. PubMed ID: 11601846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression of the Cre recombinase in actinomycetes.
    Fedoryshyn M; Welle E; Bechthold A; Luzhetskyy A
    Appl Microbiol Biotechnol; 2008 Apr; 78(6):1065-70. PubMed ID: 18299828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages.
    Sauer B; McDermott J
    Nucleic Acids Res; 2004; 32(20):6086-95. PubMed ID: 15550568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific recombination of asymmetric lox sites mediated by a heterotetrameric Cre recombinase complex.
    Saraf-Levy T; Santoro SW; Volpin H; Kushnirsky T; Eyal Y; Schultz PG; Gidoni D; Carmi N
    Bioorg Med Chem; 2006 May; 14(9):3081-9. PubMed ID: 16412655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excision of selectable genes from transgenic goat cells by a protein transducible TAT-Cre recombinase.
    Xu Y; Liu S; Yu G; Chen J; Chen J; Xu X; Wu Y; Zhang A; Dowdy SF; Cheng G
    Gene; 2008 Aug; 419(1-2):70-4. PubMed ID: 18547746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed integration system using a combination of mutant lox sites for Corynebacterium glutamicum.
    Suzuki N; Inui M; Yukawa H
    Appl Microbiol Biotechnol; 2007 Dec; 77(4):871-8. PubMed ID: 17938910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of deletion mutation on the recombination activity of Cre recombinase.
    Rongrong L; Lixia W; Zhongping L
    Acta Biochim Pol; 2005; 52(2):541-4. PubMed ID: 15912212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase.
    Nolden L; Edenhofer F; Haupt S; Koch P; Wunderlich FT; Siemen H; Brüstle O
    Nat Methods; 2006 Jun; 3(6):461-7. PubMed ID: 16721380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA topology and geometry in Flp and Cre recombination.
    Vetcher AA; Lushnikov AY; Navarra-Madsen J; Scharein RG; Lyubchenko YL; Darcy IK; Levene SD
    J Mol Biol; 2006 Apr; 357(4):1089-104. PubMed ID: 16483600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stringent dual control system overseeing transcription and activity of the Cre recombinase for the liver-specific conditional gene knock-out mouse model.
    Wu Y; He Y; Zhang H; Dai X; Zhou X; Gu J; Wang G; Zhu J
    J Genet Genomics; 2008 Jul; 35(7):431-9. PubMed ID: 18640622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of site-specific recombinase (SSR) technology.
    Bucholtz F
    J Vis Exp; 2008 May; (15):. PubMed ID: 19066587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel recombination system using Cre recombinase alpha complementation.
    Seidi A; Mie M; Kobatake E
    Biotechnol Lett; 2007 Sep; 29(9):1315-22. PubMed ID: 17530179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S Phase-preferential Cre-recombination in mammalian cells revealed by HIV-TAT-PTD-mediated protein transduction.
    Hashimoto M; Taniguchi M; Yoshino S; Arai S; Sato K
    J Biochem; 2008 Jan; 143(1):87-95. PubMed ID: 17965427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombination system based on cre alpha complementation and leucine zipper fusions.
    Seidi A; Mie M; Kobatake E
    Appl Biochem Biotechnol; 2009 Aug; 158(2):334-42. PubMed ID: 19002610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redesign of the monomer-monomer interface of Cre recombinase yields an obligate heterotetrameric complex.
    Zhang C; Myers CA; Qi Z; Mitra RD; Corbo JC; Havranek JJ
    Nucleic Acids Res; 2015 Oct; 43(18):9076-85. PubMed ID: 26365240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of spacer regions derived from intramolecular recombination between heterologous loxP sites.
    Jung UJ; Park S; Lee G; Shin HJ; Kwon MH
    Biochem Biophys Res Commun; 2007 Nov; 363(1):183-9. PubMed ID: 17826735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nearest-neighbor amino acids of specificity-determining residues influence the activity of engineered Cre-type recombinases.
    Soni A; Augsburg M; Buchholz F; Pisabarro MT
    Sci Rep; 2020 Aug; 10(1):13985. PubMed ID: 32814809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Split-CreERT2: temporal control of DNA recombination mediated by split-Cre protein fragment complementation.
    Hirrlinger J; Requardt RP; Winkler U; Wilhelm F; Schulze C; Hirrlinger PG
    PLoS One; 2009 Dec; 4(12):e8354. PubMed ID: 20016782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.